P04.72 Using Mendelian randomization to find potential novel drug targets for the treatment of glioma

BACKGROUND: There are about 12,000 new brain tumours each year in the UK. Around 50% of these are gliomas, of which the majority are the highly aggressive glioblastoma multiforme (GBM) subtype. The median survival rate of GBM is 15 months. The treatment regime for glioma has remained relatively stat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Robinson, J W, Zheng, J, Tsavachidis, S, Haycock, P, Bondy, M, Relton, C, Martin, R, Smtih, G D, Kurian, K M
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Poster Presentations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144652/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.306
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados